Comparison of treatment of patients with congestive heart failure by cardiologists versus noncardiologists

American Journal of Health-System Pharmacy

Volumn 62, Issue 2, 2005, Pages 168-172

  Patel, Jean A ^a,b   Fotis, Michael A ^a,b  

^a Drug Information Service   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Aldosterone antagonists; Angiotensin converting enzyme inhibitors; Cardiac drugs; Digoxin; Heart failure; Heart Failure Society of America; Hospitals; Physicians; Prescribing; Protocols; Sympatholytic agents

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; NITRATE;

ADULT; AGED; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HEART CATHETERIZATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NUCLEAR MEDICINE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; THORAX RADIOGRAPHY; TREATMENT OUTCOME; WEIGHT;

EID: 18744389494     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/62.2.168     Document Type: Review

References (14)

1. Heart disease and stroke statistics - 2003 update. Dallas: American Heart Association; 2002.
2. Agency for Healthcare Research and Quality. Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients and cost-effectiveness. www.ahrq.gof/clinicepcsums/ hrtfailsum.htm (accessed 2004 Dec 3).
3. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacological approaches. Pharmacotherapy. 2000; 20:495-522.
4. Reis SE, Holubkov R, Edmundowicz D et al. Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. J Am Coll Cardiol. 1997; 30:733-8.
5. Philbin EF, Jenkins PL. Differences between patients with heart failure treated by cardiologists, internists, family physicians and other physicians: analysis of a large, statewide database. Am Heart J. 2000; 139:491-6.
6. Edep ME, Shah NB, Tateo IM et al. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997; 30:518-26.
7. American College of Cardiology-American Heart Association. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. www.acc.org/clinical/guidelines/failure/hf_index.htm (accessed 2003 Oct 2).
8. Nohria A, Chen YT, Morton DJ et al. Quality of care for patients hospitalized with heart failure at academic medical centers. Am Heart J. 1999; 137:1028-34.
9. Krumholz HM, Wang Y, Parent EM et al. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med. 1997; 157:2242-7.
10. The Large State Peer Review Organization Consortium. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med. 1997; 157:1103-8.
11. SEOSI Investigators. Survey on heart failure in Italian hospital cardiology units. Results of the SEOSI study. Eur Heart J. 1997; 18:1457-64.
12. Lowe JM, Candish PM, Henry DA et al. Management and outcomes of congestive heart failure: a prospective study of hospitalized patients. Med J Aust. 1998; 168:115-8.
13. Philbin EF, Andreaou C, Rocco TA et al. Patterns of angiotensin- converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 1996; 77:832-8.
14. Kennedy AG, MacLean CD. Clinical inertia: errors of omission in drug therapy. Am J Health-Syst Pharm. 2004; 61:401-4.